Ellomay Capital Reports Results for the Three Months Ended March 31, 2024

TEL-AVIV, Israel, June 30, 2024 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited financial results for the three month period ended March 31, 2024.

Financial Highlights

    --  Total assets as of March 31, 2024 amounted to approximately EUR666.8
        million, compared to total assets as of December 31, 2023 of
        approximately EUR612.9 million.

    --  Revenues(1) for the three months ended March 31, 2024 were approximately
        EUR8.2 million, compared to revenues of approximately EUR11.7 million
        for the three months ended March 31, 2023.

    --  Loss from continuing operations for the three months ended March 31,
        2024 was approximately EUR4.6 million, compared to net profit from
        continuing operations of approximately EUR3 million for the three months
        ended March 31, 2023. Loss for the three months ended March 31, 2024 was
        approximately EUR4.9 million, compared to net profit of approximately
        EUR3.3 million for the three months ended March 31, 2023.

    --  EBITDA for the three months ended March 31, 2024 was approximately
        EUR1.6 million, compared to EBITDA of approximately EUR4.2 million for
        the three months ended March 31, 2023. See below under "Use of Non-IFRS
        Financial Measures" for additional disclosure concerning EBITDA.

    --  On December 31, 2023, the Company executed an agreement to sell its
        holdings in the 9 MW solar plant located in Talmei Yosef. The sale was
        consummated following the balance sheet date, on June 3, 2024, and the
        net consideration received at closing was approximately NIS 42.6 million
        (approximately EUR10.6 million). In connection with the expected sale,
        the Company presents the results of this solar plant as a discontinued
        operation and the results for the three months ended March 31, 2023 were
        adjusted accordingly.

Financial Overview for the Three Months Ended March 31, 2024

    --  Revenues were approximately EUR8.2 million for the three months ended
        March 31, 2024, compared to approximately EUR11.7 million for the three
        months ended March 31, 2023.  The decrease in revenues mainly results
        from the decrease in electricity prices in Spain.

    --  Operating expenses were approximately EUR4.6 million for the three
        months ended March 31, 2024, compared to approximately EUR6.4 million
        for the three months ended March 31, 2023. The decrease in operating
        expenses mainly results from a decrease in direct taxes on turnover paid
        by the Company's Spanish subsidiaries as a result of reduced electricity
        prices. The operating expenses of the Company's Spanish subsidiaries for
        the three months ended March 31, 2023 were impacted by the Spanish RDL
        17/2022, which established the reduction of returns on the electricity
        generating activity of Spanish production facilities that do not emit
        greenhouse gases, accomplished through payments of a portion of the
        revenues by the production facilities to the Spanish government.
        Depreciation and amortization expenses were approximately EUR4.1 million
        for the three months ended March 31, 2024, compared to approximately
        EUR4 million for the three months ended March 31, 2023.

    --  Project development costs were approximately EUR1.4 million for the
        three months ended March 31, 2024, compared to approximately EUR1.2
        million for the three months ended March 31, 2023. The increase in
        project development costs is mainly due to development expenses in
        connection with solar projects in the USA, Italy, and Israel.

    --  General and administrative expenses were approximately EUR1.6 million
        for the three months ended March 31, 2024, compared to approximately
        EUR1.4 million for the three months ended March 31, 2023. The increase
        in general and administrative expenses is mostly due to higher
        consultancy expenses.

    --  The Company's share of profits of equity accounted investee, after
        elimination of intercompany transactions, was approximately EUR1.3
        million for the three months ended March 31, 2024, compared to
        approximately EUR1.2 million for the three months ended March 31, 2023.
        The increase in share of profits of equity accounted investee was mainly
        due to lower financing expenses incurred by Dorad for the period as a
        result of the CPI indexation of loans from banks.

    --  Financing expenses, net, were approximately EUR3.3 million for the three
        months ended March 31, 2024, compared to financing income of
        approximately EUR1.7 million for the three months ended March 31, 2023.
        The increase in financing expenses, net, was mainly attributable to
        expenses resulting from exchange rate differences amounted to
        approximately EUR0.5 million for the three months ended March 31, 2024,
        compared to income resulting from exchange rate differences of
        approximately EUR4.4 million for the three months ended March 31, 2023,
        an aggregate change of approximately EUR5.1 million. The exchange rate
        differences were mainly recorded in connection with the New Israeli
        Shekel ("NIS") cash and cash equivalents and the Company's NIS
        denominated debentures and were caused by the 0.8% appreciation of the
        NIS against the euro during the three months ended March 31, 2024,
        compared to a 4.8% devaluation of the NIS against the euro during the
        three months ended March 31, 2023. The increase in financing expenses
        was partially offset by an increase in financing income of approximately
        EUR0.5 million in connection with derivatives and warrants in the three
        months ended March 31, 2024, compared to the three months ended March
        31, 2023.

    --  Tax benefit was approximately EUR0.8 million for the three months ended
        March 31, 2024, compared to taxes on income of approximately EUR1.4
        million in three months ended March 31, 2023. The change in tax is
        mainly due to deferred tax recorded in connection with carry forward
        loss for which deferred tax were not previously recorded, partially
        offset by the decrease in electricity prices in Spain, resulting in
        lower taxable income of the Company's Spanish subsidiaries.

    --  Loss from discontinued operation (net of tax) was approximately EUR0.3
        million for the three months ended March 31, 2024, compared to a profit
        from discontinued operation of approximately EUR0.2 million for the
        three months ended March 31, 2023.

    --  Loss for the three months ended March 31, 2024 was approximately EUR4.9
        million, compared to net profit of approximately EUR3.3 million for the
        three months ended March 31, 2023.

    --  Total other comprehensive income was approximately EUR12 million for
        three months ended March 31, 2024, compared to total other comprehensive
        loss of approximately EUR26.6 million in three months ended March 31,
        2023. The change in total other comprehensive loss mainly results from
        changes in fair value of cash flow hedges, including a material decrease
        in the fair value of the liability resulting from the financial power
        swap that covers approximately 80% of the output of the Talasol solar
        plant (the "Talasol PPA"). The Talasol PPA experienced a high volatility
        due to the substantial change in electricity prices in Europe. In
        accordance with hedge accounting standards, the changes in the Talasol
        PPA's fair value are recorded in the Company's shareholders' equity
        through a hedging reserve and not through the accumulated
        deficit/retained earnings. The changes do not impact the Company's
        consolidated net profit/loss or the Company's consolidated cash flows.

    --  Total comprehensive income was approximately EUR7.1 million for the
        three months ended March 31, 2024, compared to total comprehensive loss
        of approximately EUR29.9 million for the three months ended March 31,
        2023.

    --  EBITDA was approximately EUR1.6 million for the three months ended March
        31, 2024, compared to approximately EUR4.2 million for the three months
        ended March 31, 2023.

    --  Net cash from operating activities was approximately EUR1.2 million for
        the three months ended March 31, 2024, compared to approximately EUR1.8
        million for the three months ended March 31, 2023.

    --  On January 16, 2024, the Company issued in an Israeli public offering
        units consisting of an aggregate principal amount of NIS 170 million of
        its newly issued Series F Debentures, due March 31, 2030, and the Series
        2 Options to purchase an aggregate of 1,020,000 ordinary shares at a
        price per share of NIS 80 (subject to customary adjustments), which
        expire on January 5, 2028. The net proceeds of the offering, net of
        related expenses such as consultancy fee and commissions, were
        approximately NIS 165 million (approximately EUR40 million as of the
        issuance date).On April 17, 2024, the Company issued NIS 40 million par
        value of the Series F Debentures in a private placement to Israeli
        classified investors for an aggregate gross consideration of
        approximately NIS 37.8 million (approximately EUR9.4 million as of the
        issuance date), reflecting a price of NIS 0.946 per NIS 1 principal
        amount of the Series F Debentures. Following completion of the private
        placement, the aggregate outstanding par value of the Company's Series F
        Debentures is NIS 210 million.

CEO Review for the First Quarter of 2024

Revenues in the first quarter of 2024 were approximately EUR8.2 million, compared to revenues of approximately EUR11.7 million in the corresponding quarter last year. Most of the decrease in revenues was due to the drop in prices in Spain, which subtracted approximately EUR3 million from the revenues.

Operating expenses in the first quarter of 2024 decreased by approximately EUR1.8 million compared to the corresponding quarter last year. Project development expenses in the first quarter of 2024 increased by approximately EUR0.3 million compared to the corresponding quarter last year. Project development expenses included non-recurring expenses of approximately EUR0.8 million. Excluding such non-recurring expenses, there was a decrease in project development expenses.

Activity in Spain:

In May 2024, the Ellomay Solar project (capacity of 28 MW) reached financial closing of project finance in the amount of EUR10 million for 16 years at an annual interest rate, fixed through an interest rate swap deal, of approximately 3%. After receiving the financing, the majority of the equity invested in the project was returned.

In the first quarter of 2024, the trend of a strong decrease in electricity prices in Europe continued, with the exception of Italy where prices remained stable. The decrease in electricity prices in Spain was approximately 70% compared to the corresponding quarter in 2023. The most significant decrease was in March 2024, in which prices decreased by approximately 90% compared to the corresponding quarter in 2023. The main reasons for the decrease in prices in Spain during the first quarter are the relatively warm winter by 6 to 8 degrees (Celsius) above average on the one hand and substantial rainfall that caused a sharp increase in hydroelectric power generation on the other hand, when in March alone the power generation from hydro sources jumped from 2000 GW in the corresponding month in 2023 to 4700 GW. The high output of hydroelectricity also caused a corresponding decrease in the prices of green certificates. A return to normative prices was recorded only in June 2024. In the Company's estimation, this is an unusual event that affected the entire electricity sector in Europe.

Despite the significant drop in electricity prices in Spain, the Company's revenues from the sale of electricity in Spain for the first quarter of 2024 did not decrease at the same rate, and stood at approximately EUR4.2 million, compared to revenues of approximately EUR7.2 million in the corresponding quarter last year. The main reason for the significant drop in electricity prices in Spain not fully impacting the Company's revenues is that most of the electricity the Company sells in Spain is under a long-term PPA.

Activity of Dorad:

In the first quarter of 2024, the Dorad power plant recorded an increase in profit, with net profit of approximately NIS 65.6 million, an increase of approximately NIS 11.7 million compared to the corresponding quarter last year. The Dorad power station received the approval of the National Infrastructures Committee and a positive connection survey to increase the capacity by an additional 650 MW. In addition, as of July 1, 2024, the power plant will participate in the system manager's supply tenders.

Activity in the USA:

In the USA, the development and construction activities of solar projects are progressing at a rapid pace and the construction of the first four projects, with a total capacity of approximately 49 MW, began in early 2024. Completion of construction and connection to the grid of two projects (in an aggregate capacity of approximately 27 MW) is expected by the end of 2024 and of the other two projects (in an aggregate capacity of approximately 22 MW) is expected in early 2025. Additional projects with an aggregate capacity of approximately 30-40 MW intended for construction in 2025 are under development.

Activity in Italy:

In Italy, the construction of a solar project with a capacity of approximately 18 MW (ELLO 10) has begun, and its construction is expected to be completed in September 2024, this is in addition to solar projects with a capacity of 20 MW whose construction has been completed. Of the 20 MW whose construction has been completed, 10 MW were connected to the grid in the first quarter of 2024 and another 10 MW are expected to be connected soon. Therefore, the increase in income from the sale of electricity in Italy will be reflected mainly in the second half of 2024. The construction prices of solar projects in Italy are declining from record levels of approximately EUR900 thousand per MW to approximately EUR675 thousand as of today, and the trend may continue. The Company is negotiating with the contractor for construction agreements adjusted to the new market prices. In addition to the 20 MW built and the 18 MW under construction, the Company has 467 MW of solar projects under development, of which 165 MW are ready for construction and 302 MW are in very advanced stages.

New legislation in Italy prohibits the establishment of new projects on agricultural land. This prohibition increases the value of the Company's portfolio, which is not located on agricultural land. The Company estimates that new possibilities are emerging for obtaining a PPA in Italy, therefore it is expected that project financing will be possible more easily and at lower costs. Considering these developments, and the decrease in construction costs, the Company believes that its decision to slow down the pace of construction commencements to meet lower construction and financing costs was correct. Electricity prices in Italy maintain a stable level. Italy is the only country in Europe where no negative electricity prices were recorded. The main reason is local gas-based electricity generation, and no change is expected in the short and medium term.

Activity in Israel:

The Manara Cliff Pumped Storage Project (Company's share is 83.34%): A project with a capacity of 156 MW, which is in advanced construction stages. The Iron Swords War, which commenced on October 7, 2023, stopped the construction work on the project. The project has protection from the state for damages and losses due to the war within the framework of the tariff regulation (covenants that support financing). The project was expected to reach commercial operation during the first half of 2027 and the continuation of the Iron Swords war will cause a delay in the date of activation. The Israeli Electricity Authority currently approved a postponement of ten months of the dates for the project. The Company and its partner in the project, Ampa, invested the equity required for the project (other than linkage differences), and the remainder of the funding is from a consortium of lenders led by Mizrahi Bank, at a scope of approximately NIS 1.18 billion.

Development of Solar licenses combined with storage:

    1. The Komemiyut and Qelahim Projects: each intended for 21 solar MW and 50
       MW / hour batteries. The sale of electricity will be conducted through a
       private supplier. Commencement of construction is planned for the first
       quarter of 2025.The Company waived the rights it won in a solar / battery
       tender process in connection with these projects and therefore paid a
       forfeiture of guarantee in the amount of NIS 1.8 million and is in
       advanced negotiations with a local supplier for the execution of a
       long-term PPA.


    2. The Talmei Yosef Project: intended for 10 solar MW and 22 MW / hour
       batteries. The request for zoning approval was approved in the fourth
       quarter of 2023.
    3. The Talmei Yosef Storage Project in Batteries: there is a zoning approval
       for approximately 400 MW / hour. The project is designed for the
       regulation of high voltage storage.

The Company also has approximately 46 solar MW under preliminary planning stages.

Activity in the Netherlands:

During the first quarter of 2024, the operational improvement in the Company's biogas plants continued and high production levels were maintained. In addition, significant progress was made in the process of obtaining the licenses to increase production by about 50% in the three plants. Increasing production will require only small investments and is expected to increase income and EBITDA. The establishment of the new government in the Netherlands enables the continuation of the legislative process mandating the obligation to mix green gas with fossil gas and the conclusion of the legislative process is expected soon. This legislation is expected to have a positive effect on the prices of green gas and the price of the accompanying green certificates.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 18 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are listed on the NYSE American and the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

    --  Approximately 335.9 MW of photovoltaic power plants in Spain (including
        a 300 MW photovoltaic plant in owned by Talasol, which is 51% owned by
        the Company) and approximately 9.95 MW of photovoltaic power plants in
        Italy;

    --  9.375% indirect interest in Dorad Energy Ltd., which owns and operates
        one of Israel's largest private power plants with production capacity of
        approximately 850MW, representing about 6%-8% of Israel's total current
        electricity consumption;

    --  Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland
        B.V., project companies operating anaerobic digestion plants in the
        Netherlands, with a green gas production capacity of approximately 3
        million, 3.8 million and 9.5 million Nm3 per year, respectively;

    --  83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a
        project to construct a 156 MW pumped storage hydro power plant in the
        Manara Cliff, Israel;

    --  A photovoltaic plant with installed capacity of approximately 10 MW in
        the Lazio Region, Italy that is ready for connection to the grid;

    --  Ellomay Solar Italy Ten SRL that is construction a photovoltaic plant
        (18 MW) in Italy;

    --  Ellomay Solar Italy Four SRL (15.06 MW), Ellomay Solar Italy Five SRL
        (87.2 MW), Ellomay Solar Italy Seven SRL (54.77 MW), Ellomay Solar Italy
        Nine SRL (8 MW) and Ellomay Solar Italy Fifteen SRL (10 MW) that are
        developing photovoltaic projects in Italy that have reached "ready to
        build" status; and

    --  Fairfield Solar Project, LLC (13.44 MW), Malakoff Solar I, LLC (6.96 MW)
        and Malakoff Solar II, LLC (6.96 MW), that are constructing photovoltaic
        plants and Mexia Solar I, LLC (5.6 MW), Mexia Solar II, LLC (5.6 MW),
        and Talco Solar, LLC (10.3 MW), that are developing photovoltaic
        projects that have reached "ready to build" status, all in the Dallas
        Metropolitan area, Texas.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including changes in electricity prices and demand, continued war and hostilities in Israel and Gaza, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, the impact of continued military conflict between Russia and Ukraine, technical and other disruptions in the operations or construction of the power plants owned by the Company and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: hilai@ellomay.com


                                                                                                         
            Ellomay Capital Ltd. and its Subsidiaries



     
              Condensed Consolidated Statements of Financial Position




                                                                                                                   March 31,                        December 31,  March 31,


                                        
            
              2024                                                         2023                                2024


                                                          Unaudited                                                 Audited                           Unaudited


                                  
            
              EUR in thousands                                           Convenience
                                                                                                                  Translation
                                                                                                  into US$ in thousands*



     
              Assets



     
              Current assets:



     Cash and cash equivalents                                                                                        82,722                              51,127      89,421



     Short term deposits                                                                                               1,045                                 997       1,130



     Restricted cash                                                                                                     729                                 810         788



     Intangible asset from green certificates                                                                            436                                 553         471



     Trade and other receivables                                                                                      12,229                              11,717      13,219



     Derivatives asset short-term                                                                                      1,403                                 275       1,517



     Assets of disposal groups classified as held for sale                                                            27,959                              28,297      30,223


                                                                                                                      126,523                              93,776     136,769



     
              Non-current assets



     Investment in equity accounted investee                                                                          33,354                              31,772      36,055



     Advances on account of investments                                                                                  898                                 898         971



     Fixed assets                                                                                                    421,149                             407,982     455,255



     Right-of-use asset                                                                                               31,738                              30,967      34,308



     Restricted cash and deposits                                                                                     16,343                              17,386      17,667



     Deferred tax                                                                                                      5,559                               8,677       6,009



     Long term receivables                                                                                            11,164                              10,446      12,068



     Derivatives                                                                                                      20,082                              10,948      21,708


                                                                                                                      540,287                             519,076     584,041





     
              Total assets                                                                                         666,810                             612,852     720,810





     
              Liabilities and Equity



     
              Current liabilities



     Current maturities of long-term bank loans                                                                        9,710                               9,784      10,496



     Current maturities of long-term loans                                                                             5,000                               5,000       5,405



     Current maturities of debentures                                                                                 34,478                              35,200      37,270



     Trade payables                                                                                                    9,159                               5,249       9,900



     Other payables                                                                                                   14,357                              10,859      15,520



     Current maturities of derivatives                                                                                     -                              4,643



     Current maturities of lease liabilities                                                                             741                                 700         801



     Liabilities of disposal groups classified as held for sale                                                       17,409                              17,142      18,819


                                                                                                                       90,854                              88,577      98,211



     
              Non-current liabilities



     Long-term lease liabilities                                                                                      24,488                              23,680      26,471



     Long-term bank loans                                                                                            238,999                             237,781     258,354



     Other long-term loans                                                                                            28,618                              29,373      30,936



     Debentures                                                                                                      144,633                             104,887     156,346



     Deferred tax                                                                                                      2,588                               2,516       2,798



     Other long-term liabilities                                                                                       4,379                                 939       4,734


                                                                                                                      443,705                             399,176     479,639



     
              Total liabilities                                                                                    534,559                             487,753     577,850



     
              Equity



     Share capital                                                                                                    25,613                              25,613      27,687



     Share premium                                                                                                    86,189                              86,159      93,169



     Treasury shares                                                                                                 (1,736)                            (1,736)    (1,877)



     Transaction reserve with non-controlling Interests                                                                5,697                               5,697       6,158



     Reserves                                                                                                         10,955                               4,299      11,842



     Accumulated deficit                                                                                             (8,650)                            (5,037)    (9,351)



     Total equity attributed to shareholders of
             
            the Company                                        118,068                             114,995     127,628



     Non-Controlling Interest                                                                                         14,183                              10,104      15,332



     
              Total equity                                                                                         132,251                             125,099     142,960



     
              Total liabilities and equity                                                                         666,810                             612,852     720,810



     * Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)


                                                                                                                                                                                                                              
          Ellomay Capital Ltd. and its Subsidiaries



              
                Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss)




                                                                                                                                                                                                     For the three months                                              For the year                     For the three months
                                                                                                                                                                                     ended March 31,                                             ended December 31,                     ended March 31,


                                                                   
              
                2024                                                                                    **2023                                      2023                                               2024


                                                                                                Unaudited                                                                          Audited                                Unaudited


                                          
              
                
                  EUR in thousands (except per share data)                                                                                 Convenience
                                                                                                                                                                                    Translation into
                                                                                                                                                                                          US$*



              Revenues                                                                                                                                                              8,243                                    11,733                                             48,834                                     8,911



              Operating expenses                                                                                                                                                  (4,563)                                  (6,368)                                          (22,861)                                  (4,933)



              Depreciation and amortization expenses                                                                                                                              (4,055)                                  (3,995)                                          (16,012)                                  (4,383)



              
                Gross profit (loss)                                                                                                                                      (375)                                    1,370                                              9,961                                     (405)





              Project development costs                                                                                                                                           (1,415)                                  (1,164)                                           (4,465)                                  (1,530)



              General and administrative expenses                                                                                                                                 (1,620)                                  (1,433)                                           (5,283)                                  (1,751)



              Share of profits of equity accounted investee                                                                                                                         1,286                                     1,178                                              4,320                                     1,390



              
                Operating profit (loss)                                                                                                                                (2,124)                                     (49)                                             4,533                                   (2,296)





              Financing income                                                                                                                                                        631                                     4,747                                              8,747                                       682



              Financing income in connection with derivatives and warrants, net                                                                                                       536                                        86                                                251                                       579



              Financing expenses in connection with projects finance                                                                                                              (1,501)                                  (1,544)                                           (6,077)                                  (1,623)



              Financing expenses in connection with debentures                                                                                                                    (1,711)                                    (828)                                           (3,876)                                  (1,850)



              Interest expenses on minority shareholder loan                                                                                                                        (554)                                    (465)                                           (2,014)                                    (599)



              Other financing expenses                                                                                                                                              (713)                                    (267)                                             (588)                                    (771)



              Financing income (expenses), net                                                                                                                                    (3,312)                                    1,729                                            (3,557)                                  (3,582)



              
                Profit (loss) before taxes on income                                                                                                                   (5,436)                                    1,680                                                976                                   (5,878)



              Tax benefit                                                                                                                                                             828                                     1,352                                              1,436                                       895



              
                Profit (loss) from continuing operations                                                                                                               (4,608)                                    3,032                                              2,412                                   (4,983)



              
                Profit (loss) from discontinued operation (net of tax)                                                                                                   (312)                                      242                                            (1,787)                                    (337)



              
                Profit (loss) for the period                                                                                                                           (4,920)                                    3,274                                                625                                   (5,320)



              
                Profit (loss) attributable to:



              Owners of the Company                                                                                                                                               (3,613)                                    4,081                                              2,219                                   (3,906)



              Non-controlling interests                                                                                                                                           (1,307)                                    (807)                                           (1,594)                                  (1,414)



              
                Profit (loss) for the period                                                                                                                           (4,920)                                    3,274                                                625                                   (5,320)





              
                Other comprehensive income items



              
                That after initial recognition in comprehensive income were
     or will be transferred to profit or loss:



              Foreign currency translation differences for foreign operations                                                                                                       1,124                                   (5,550)                                           (7,949)                                    1,215



              Effective portion of change in fair value of cash flow hedges                                                                                                        10,461                                    34,405                                             39,431                                    11,308



              Net change in fair value of cash flow hedges                                                                                                                            457                                   (2,231)                                             9,794                                       494


              transferred to profit or loss



              Total other comprehensive income                                                                                                                                     12,042                                    26,624                                             41,276                                    13,017





              
                Total other comprehensive income 
                attributable to:



              Owners of the Company                                                                                                                                                 6,656                                    11,015                                             16,931                                     7,195



              Non-controlling interests                                                                                                                                             5,386                                    15,609                                             24,345                                     5,822



              
                Total other comprehensive income                                                                                                                        12,042                                    26,624                                             41,276                                    13,017



              
                Total comprehensive
                 income
                 for the
                 period                                                                         7,122                                    29,898                                             41,901                                     7,697





              
                Total comprehensive income for the period attributable to:



              Owners of the Company                                                                                                                                                 3,043                                    15,096                                             19,150                                     3,289



              Non-controlling interests                                                                                                                                             4,079                                    14,802                                             22,751                                     4,408



              
                Total comprehensive income for the period                                                                                                                7,122                                    29,898                                             41,901                                     7,697





              * Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)



              ** The results of the Talmei Yosef solar plant have been reclassified as a discontinued operation and the results for these periods have been adjusted accordingly.


                                                                                                                                                                 
          Ellomay Capital Ltd. and its Subsidiaries



     
                Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (Loss) (con't)




                                                                                                                                               For the three                                              For the year                     For the three
                                                                                                                                                   months                                                                                      months
                                                                                                                               ended March 31,                                      ended December 31,                     ended March 31,


                                       
              
                2024                                                             2023                               2023                                               2024


                                                                    Unaudited                                                Audited                         Unaudited


              
              
                
                  EUR in thousands (except per share data)                                                   Convenience
                                                                                                                              Translation into
                                                                                                                                    US$*





     
                Basic profit (loss) per share                                                                              (0.28)                              0.27                                               0.17                             (0.31)



     
                Diluted profit (loss) per share                                                                            (0.28)                              0.27                                               0.17                             (0.31)





     
                Basic profit (loss) per share continuing operations                                                        (0.31)                              0.25                                               0.31                             (0.34)



     
                Diluted profit (loss) per share continuing operations                                                      (0.31)                              0.25                                               0.31                             (0.34)





     
                Basic profit (loss) per share discontinued operation                                                       (0.02)                              0.02                                             (0.14)                            (0.02)



     
                Diluted profit (loss) per share discontinued operation                                                     (0.02)                              0.02                                             (0.14)                             (0.02



     * Convenience translation into US$ (exchange rate as at March 31, 2023: euro 1 = US$ 1.081)


                                                                                                                                                                                                                   
     Ellomay Capital Ltd. and its Subsidiaries



              
                Condensed Consolidated Interim Statements of Changes in Equity




                                                                                                                                                    
         
           Attributable to shareholders of the Company                                                Non-
                                                                                                                                                                                                                                                                  controlling         Total


                                                                                                    Interests        Equity


                                                                                                                                                                                       Interests
                                                                                                                                                                                      Transaction
                                                                                                                                                                                      reserve with

                                                                                                                                            Translation                                   non-
                                                                                                                                               reserve                                controlling
                                                                                                                                                from                                    Interests

                                                                                                                                              foreign
                                                                                                                                             operations

                                                               Share                                  Share       Accumulated                 Treasury                                  Hedging
                                                               capital                               premium         Deficit                   shares                                    Reserve                          Total


                                                                                                              
     
          EUR 
       in thousands





              
                For the three months



              
                ended March 31, 2024 (unaudited):



              
                Balance as at January 1, 2024                                              25,613           86,159                    (5,037) (1,736)                                385         3,914            5,697     114,995                              10,104        125,099



              
                Loss for the period                                                             -                                   (3,613)                                                                            (3,613)                            (1,307)       (4,920)



              
                Other comprehensive income for the period                                       -                                                                                1,088         5,568                       6,656                               5,386         12,042



              
                Total comprehensive income for the period                                       -                                   (3,613)                                      1,088         5,568                       3,043                               4,079          7,122


                            Transactions with owners of the Company, recognized directly in equity:



              
                Share-based payments                                                            -              30                                                                                                            30                                                30



              
                Balance as at March 31, 2024                                               25,613           86,189                    (8,650) (1,736)                              1,473         9,482            5,697     118,068                              14,183        132,251





              For the three months



              ended March 31, 2023 (unaudited):



              Balance as at January 1, 2023                                                           25,613           86,038                    (7,256) (1,736)                              7,970      (20,602)           5,697      95,724                            (12,647)        83,077



              Profit for the period                                                                        -                                     4,081                                                                               4,081                               (807)         3,274



              Other comprehensive income for the period                                                    -                                                                              (5,292)       16,307                      11,015                              15,609         26,624



              Total comprehensive income for the period                                                    -                                     4,081                                     (5,292)       16,307                      15,096                              14,802         29,898



              Transactions with owners of the Company,
    recognized directly in equity:



              Share-based payments                                                                         -              31                                                                                                            31                                                31



              Balance as at March 31, 2023                                                            25,613           86,069                    (3,175) (1,736)                              2,678       (4,295)           5,697     110,851                               2,155        113,006


                                                                                                                                                                                                                        
     Ellomay Capital Ltd. and its Subsidiaries



              
                Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




                                                                                                                                                      
          
            Attributable to shareholders of the Company                                                 Non-
                                                                                                                                                                                                                                                                       controlling       Total


                                                                                                    Interests        Equity


                                                                                                                                                                                            Interests
                                                                                                                                                                                           Transaction
                                                                                                                                                                                           reserve with

                                                                                                                                              Translation                                      non-
                                                                                                                                              reserve from                                 controlling
                                                                                                                                                                                             Interests

                                                                                                                                                foreign
                                                                                                                                               operations

                                                            Share                                     Share       Accumulated                   Treasury                                     Hedging
                                                            capital                                  premium         Deficit                     shares                                       Reserve                          Total


                                                                                                              
     
              EUR 
     in thousands



              
                For the year ended



              
                December 31, 2023 (audited):



              
                Balance as at January 1, 2023                                              25,613           86,038                       (7,256)  (1,736)                               7,970      (20,602)           5,697      95,724                            (12,647)      83,077



              
                Profit for the year                                                             -                                        2,219                                                                                 2,219                             (1,594)         625



              
                Other comprehensive income for the year                                         -                                                                                   (7,585)       24,516                      16,931                              24,345       41,276



              
                Total comprehensive income for the year                                         -                                        2,219                                       (7,585)       24,516                      19,150                              22,751       41,901



              
                Transactions with owners of the Company,
    recognized directly in equity:



              
                Share-based payments                                                            -             121                                                                                                                121                                             121



              
                Balance as at December 31, 2023                                            25,613           86,159                       (5,037)  (1,736)                                 385         3,914            5,697     114,995                              10,104      125,099



              Ellomay Capital Ltd. and its Subsidiaries



              
                Condensed Consolidated Interim Statements of Changes in Equity (cont'd)




                                                                                                                                                                                     
              
             Attributable to shareholders of the Company                             Non-
                                                                                                                                                                                                                                                                                       controlling         Total


                                                                                                      Interests                          Equity


                                                                                                                                                                                                                                Interests
                                                                                                                                                                                                                               Transaction
                                                                                                                                                                                                                               reserve with

                                                                                                                                                                             Translation                                           non-
                                                                                                                                                                             reserve from                                      controlling
                                                                                                                                                                                                                                 Interests

                                                                                                                                                                               foreign
                                                                                                                                                                              operations

                                                              Share                                     Share                         Accumulated                              Treasury                                          Hedging
                                                             capital                                   premium                           Deficit                                shares                                            Reserve                   Total


                                                                                                    
      
            Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)



              
                For the three months



              
                ended March 31, 2024 (unaudited):



              
                
                  Balance as at January 1, 2024                                 27,687                             93,137                                  (5,445)      (1,877)                                  416         4,231     6,158     124,307                 10,924        135,231



              
                Loss for the period                                                               -                                                                   (3,906)                                                                            (3,906)               (1,414)       (5,320)



              
                Other comprehensive income for the period                                         -                                                                                                                       1,176         6,019                7,195                  5,822         13,017



              
                Total comprehensive income for the period                                         -                                                                   (3,906)                                             1,176         6,019                3,289                  4,408          7,697



              
                Transactions with owners of the Company,
    recognized directly in equity:



              
                Share-based payments                                                              -                                32                                                                                                                          32                                   32



              
                Balance as at March 31, 2024                                                 27,687                             93,169                                  (9,351)      (1,877)                                1,592        10,250     6,158     127,628                 15,332        142,960


                                                                                                                           
        Ellomay Capital Ltd. and its Subsidiaries



       
                Condensed Consolidated Interim Statements of Cash Flow




                                                                                                                  For the three                                   For the year                  For the three
                                                                                                                      months                                                                        months
                                                                                                     ended March 31,                               ended December 31,              ended March 31,


                                                         
              
                2024                  2023                           2023                                    2024


                                                       
              
                Unaudited            Audited                     Unaudited


                                                                                                                   Convenience
                                                                                                     Translation into
                                                                                                           US$*
                                             
              
                EUR 
                in thousands



       
                Cash flows from operating activities



       Profit (loss) for the period                                                                (4,920)                         3,274                                     625                         (5,320)



       
                Adjustments for:

    ---


       Financing expenses (income), net                                                              3,167                        (2,023)                                  3,034                           3,425



       Impairment losses on assets of disposal groups classified as held-for-sale                      601                                                                 2,565                             650



       Depreciation and amortization                                                                 4,084                          4,115                                  16,473                           4,414



       Share-based payment transactions                                                                 30                             31                                     121                              32



       Share of profit of equity accounted investees                                               (1,286)                       (1,178)                                (4,320)                        (1,390)



       Payment of interest on loan from an equity accounted investee                                     -                                                                1,501



       Change in trade receivables and other receivables                                           (2,342)                       (1,373)                                  (302)                        (2,532)



       Change in other assets                                                                            -                         (120)                                  (681)



       Change in receivables from concessions project                                                  315                            257                                   1,778                             341



       Change in trade payables                                                                       (68)                         (876)                                   (45)                           (74)



       Change in other payables                                                                      2,796                          1,417                                 (2,235)                          3,022



       Income tax benefit                                                                            (805)                       (1,256)                                (1,852)                          (870)



       Income taxes refund (paid)                                                                      564                                                                 (912)                            610



       Interest received                                                                               907                            493                                   2,936                             980



       Interest paid                                                                               (1,892)                         (923)                               (10,082)                        (2,045)


                                                                                                      6,071                        (1,436)                                  7,979                           6,563


                                                                                                      1,151                          1,838                                   8,604                           1,243


       Net cash from operating activities





       
                Cash flows from investing activities



       Acquisition of fixed assets                                                                 (9,020)                      (13,331)                               (58,848)                        (9,750)



       Interest paid capitalized to fixed assets                                                         -                                                              (2,283)



       Repayment of loan to an equity accounted investee                                                 -                                                                1,324



       Loan to an equity accounted investee                                                              -                          (60)                                  (128)



       Advances on account of investments                                                                -                         (382)                                  (421)



       Proceeds from advances on account of investments                                                  -                                                                2,218



       Proceeds in marketable securities                                                                 -                         2,837                                   2,837



       Investment in settlement of derivatives, net                                                     14                                                                                                   15



       Proceed from restricted cash, net                                                             1,153                            893                                     840                           1,246



       Investment in short-term deposits                                                              (28)                      (21,945)                                (1,092)                           (30)



       
                Net cash used in investing activities                                          (7,881)                      (31,988)                               (55,553)                        (8,519)





       
                Cash flows from financing activities



       Issuance of warrants                                                                          3,735                                                                                                4,037



       Cost associated with long term loans                                                          (638)                         (315)                                (1,877)                          (690)



       Payment of principal of lease liabilities                                                     (299)                         (200)                                (1,156)                          (323)



       Proceeds from long-term loans                                                                   380                            764                                  32,157                             411



       Repayment of long-term loans                                                                (2,357)                         (686)                               (12,736)                        (2,548)



       Repayment of debentures                                                                           -                                                             (17,763)



       Proceeds from issuance of debentures, net                                                    36,450                         55,808                                  55,808                          39,402



       
                Net cash from financing activities                                              37,271                         55,371                                  54,433                          40,289





       Effect of exchange rate fluctuations on cash and cash equivalents                             1,667                        (1,942)                                (2,387)                          1,804



       Increase in cash and cash equivalents                                                        32,208                         23,279                                   5,097                          34,817



       Cash and cash equivalents at the beginning of year                                           51,555                         46,458                                  46,458                          55,730



       Cash from disposal groups classified as held-for-sale                                       (1,041)                                                                (428)                        (1,125)



       
                Cash and cash equivalents at the end of the period                              82,722                         69,737                                  51,127                          89,422



       * Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)


                                                                                                                                                                                                                                                                
             Ellomay Capital Ltd. and its Subsidiaries



     
                Operating Segments




                                                                                                  Italy          Spain                                    USA                            Netherlands                         Israel                               Total


                                                                                               Subsidized 28 MV                                                                                                                              reportable                                                                 Total


                                                      PV                                         Plants     PV     Talasol          PV                      Biogas                              Dorad           Manara            PV*         segments               Reconciliations                                consolidated


                                                                                                                             
             
       
       For the three months ended March 31, 2024


                                                                                                                                         
     
     
                  EUR in thousands





     
                Revenues                                                                            71    740         245        3,180                                                              4,007         64,139                               288                        72,670                                     (64,427)          8,243



     Operating expenses                                                                                - (131)      (218)       (912)                                                           (3,302)      (47,444)                             (83)                     (52,090)                                      47,527         (4,563)



     Depreciation expenses                                                                             - (229)      (237)     (2,871)                                                             (712)       (5,704)                             (29)                      (9,782)                                       5,727         (4,055)



     
                Gross profit (loss)                                                                 71    380       (210)       (603)                                                               (7)        10,991                               176                        10,798                                     (11,173)          (375)





     
                Adjusted gross profit (loss)                                                        71    380       (210)       (603)                                                               (7)        10,991                           (1,454)                        9,168                                      (9,543)          (375)



     Project development costs                                                                                                                                                                                                                                                                                                       (1,415)



     General and administrative expenses                                                                                                                                                                                                                                                                                             (1,620)



     Share of loss of equity accounted investee                                                                                                                                                                                                                                                                                        1,286



     
                Operating profit                                                                                                                                                                                                                                                                                                   (2,124)



     Financing income                                                                                                                                                                                                                                                                                                                    631



     Financing income in connection



      with derivatives
               
              and warrants, net                                                                                                                                                                                                                                                                           536



     Financing expenses in connection with projects finance                                                                                                                                                                                                                                                                          (1,501)



     Financing expenses in connection with debentures                                                                                                                                                                                                                                                                                (1,711)



     Interest expenses on minority shareholder loan                                                                                                                                                                                                                                                                                    (554)



     Other financing expenses                                                                                                                                                                                                                                                                                                          (713)



     Financing expenses, net                                                                                                                                                                                                                                                                                                         (3,312)



     
                Loss before taxes on income                                                                                                                                                                                                                                                                                        (5,436)




                                  Segment assets as at March 31, 2024                              46,213 13,289      18,455      233,200                       15,647                                 31,105        100,514         174,819             27,959                       661,201                                        5,609         666,810



     * The results of the Talmei Yosef solar plant are presented as a discontinued operation.


                                                                                                                                                                                
          Ellomay Capital Ltd. and its Subsidiaries



     
                Reconciliation of Profit (Loss) to EBITDA




                                                                                                                                                               For the three months                                      For the year                     For the three months
                                                                                                                                               ended March 31,                                     ended December 31,                     ended March 31,


                                          
              
                2024                                                                                         **2023            2023                                               2024


                            
              
                
                  EUR in thousands                                                                                 Convenience
                                                                                                                                            Translation into US$*



     
                Net profit (loss) for the period                                                                                                           (4,920)           3,274                                                625                                   (5,320)



     
                Financing expenses (income), net                                                                                                             3,312          (1,729)                                             3,557                                     3,582



     
                Tax benefit                                                                                                                                  (828)         (1,352)                                           (1,436)                                    (895)



     
                Depreciation and amortization expenses                                                                                                       4,055            3,995                                             16,012                                     4,383



     
                EBITDA                                                                                                                                       1,619            4,188                                             18,758                                     1,750



     * Convenience translation into US$ (exchange rate as at March 31, 2024: euro 1 = US$ 1.081)



     ** The results of the Talmei Yosef PV Plant have been reclassified as a discontinued operation and the results for these periods have been adjusted accordingly.

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders

Financial Covenants

Pursuant to the Deeds of Trust governing the Company's Series C, Series D, Series E and Series F Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 7, 2023, and below.

Net Financial Debt

As of March 31, 2024, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately EUR102.5 million (consisting of approximately EUR300.2(2) million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately EUR186.3(3) million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021), the Series D Convertible Debentures issuance (in February 2021), the Series E Secured Debentures issuance (in February 2023) and the Series F Debentures issuance (in January 2024)), net of approximately EUR83.8 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately EUR300.2(4) million of project finance and related hedging transactions of the Company's subsidiaries).

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)

Information for the Company's Series C Debenture Holders.

The Deed of Trust governing the Company's Series C Debentures (as amended on June 6, 2022, the "Series C Deed of Trust"), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series C Deed of Trust) was approximately EUR117.1 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(5), was 5.5.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended March 31, 2024:


                                                                                                              For the four-quarter
                                                                                                                      period
                                                                                           ended March 31, 2024


                                                                              Unaudited


                                                                          EUR in thousands



              Loss for the period                                                                                         (7,569)



              Financing expenses, net                                                                                       8,892



              Tax benefit                                                                                                 (1,008)



              Depreciation and amortization expenses                                                                       15,952



              Share-based payments                                                                                            120



              Adjustment to revenues of the Talmei Yosef PV Plant due to                                                    2,331
    calculation based on the fixed asset model



              Adjusted EBITDA as defined the Series C Deed of Trust                                                        18,718

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)

Information for the Company's Series D Debenture Holders

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately EUR117.1 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(6) was 5.5.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended March 31, 2024:


                                                                                                              For the four-quarter
                                                                                                                      period
                                                                                           ended March 31, 2024


                                                                              Unaudited


                                                                          EUR in thousands



              Loss for the period                                                                                         (7,569)



              Financing expenses, net                                                                                       8,892



              Tax benefit                                                                                                 (1,008)



              Depreciation and amortization expenses                                                                       15,952



              Share-based payments                                                                                            120



              Adjustment to revenues of the Talmei Yosef PV Plant due to                                                    2,331
    calculation based on the fixed asset model



              Adjusted EBITDA as defined the Series D Deed of Trust                                                        18,718

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)

Information for the Company's Series E Debenture Holders

The Deed of Trust governing the Company's Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately EUR117.1 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 46.7%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(7) was 5.5.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended March 31, 2024:


                                                                                                              For the four-quarter
                                                                                                                      period
                                                                                           ended March 31, 2024


                                                                              Unaudited


                                                                          EUR in thousands



              Loss for the period                                                                                         (7,569)



              Financing expenses, net                                                                                       8,892



              Tax benefit                                                                                                 (1,008)



              Depreciation and amortization expenses                                                                       15,952



              Share-based payments                                                                                            120



              Adjustment to revenues of the Talmei Yosef PV Plant due to                                                    2,331
    calculation based on the fixed asset model



              Adjusted EBITDA as defined the Series E Deed of Trust                                                        18,718

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. ("Ellomay Luzon Energy")), which were pledged to the holders of the Company's Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of March 31, 2024, the value of the assets pledged to the holders of the Series E Debentures in the Company's books (unaudited) is approximately EUR33.4 million (approximately NIS132.7 million based on the exchange rate as of such date).

Ellomay Capital Ltd. and its Subsidiaries
Information for the Company's Debenture Holders (con't)

Information for the Company's Series F Debenture Holders

The Deed of Trust governing the Company's Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of March 31, 2024, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series F Deed of Trust) was approximately EUR116.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 46.9%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(8) was 5.5.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended March 31, 2024:


                                                                                                              For the four-quarter
                                                                                                                      period
                                                                                           ended March 31, 2024


                                                                              Unaudited


                                                                          EUR in thousands



              Loss for the period                                                                                         (7,569)



              Financing expenses, net                                                                                       8,892



              Tax benefit                                                                                                 (1,008)



              Depreciation and amortization expenses                                                                       15,952



              Share-based payments                                                                                            120



              Adjustment to revenues of the Talmei Yosef PV Plant due to                                                    2,331
    calculation based on the fixed asset model



              Adjusted EBITDA as defined the Series F Deed of Trust                                                        18,718

    1. The revenues presented in the Company's financial results included in
       this press release are based on IFRS and do not take into account the
       adjustments included in the Company's investor presentation.
    2. The amount of short-term and long-term debt from banks and other
       interest-bearing financial obligations provided above, includes an amount
       of approximately EUR4.7 million costs associated with such debt, which
       was capitalized and therefore offset from the debt amount that is
       recorded in the Company's balance sheet.
    3. The amount of the debentures provided above includes an amount of
       approximately EUR1.6 million associated costs, which was capitalized and
       therefore offset from the debentures amount that is recorded in the
       Company's balance sheet.
    4. The project finance amount deducted from the calculation of Net Financial
       Debt includes project finance obtained from various sources, including
       financing entities and the minority shareholders in project companies
       held by the Company (provided in the form of shareholders' loans to the
       project companies).
    5. The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as
       earnings before financial expenses, net, taxes, depreciation and
       amortization, where the revenues from the Company's operations, such as
       the Talmei Yosef PV Plant, are calculated based on the fixed asset model
       and not based on the financial asset model (IFRIC 12), and before
       share-based payments. The Series C Deed of Trust provides that for
       purposes of the financial covenant, the Adjusted EBITDA will be
       calculated based on the four preceding quarters, in the aggregate. The
       Adjusted EBITDA is presented in this press release as part of the
       Company's undertakings towards the holders of its Series C Debentures.
       For a general discussion of the use of non-IFRS measures, such as EBITDA
       and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
    6. The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as
       earnings before financial expenses, net, taxes, depreciation and
       amortization, where the revenues from the Company's operations, such as
       the Talmei Yosef PV Plant, are calculated based on the fixed asset model
       and not based on the financial asset model (IFRIC 12), and before
       share-based payments, when the data of assets or projects whose
       Commercial Operation Date (as such term is defined in the Series D Deed
       of Trust) occurred in the four quarters that preceded the relevant date
       will be calculated based on Annual Gross Up (as such term is defined in
       the Series D Deed of Trust). The Series D Deed of Trust provides that for
       purposes of the financial covenant, the Adjusted EBITDA will be
       calculated based on the four preceding quarters, in the aggregate. The
       Adjusted EBITDA is presented in this press release as part of the
       Company's undertakings towards the holders of its Series D Debentures.
       For a general discussion of the use of non-IFRS measures, such as EBITDA
       and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
    7. The term "Adjusted EBITDA" is defined in the Series E Deed of Trust as
       earnings before financial expenses, net, taxes, depreciation and
       amortization, where the revenues from the Company's operations, such as
       the Talmei Yosef PV Plant, are calculated based on the fixed asset model
       and not based on the financial asset model (IFRIC 12), and before
       share-based payments, when the data of assets or projects whose
       Commercial Operation Date (as such term is defined in the Series E Deed
       of Trust) occurred in the four quarters that preceded the relevant date
       will be calculated based on Annual Gross Up (as such term is defined in
       the Series E Deed of Trust). The Series E Deed of Trust provides that for
       purposes of the financial covenant, the Adjusted EBITDA will be
       calculated based on the four preceding quarters, in the aggregate. The
       Adjusted EBITDA is presented in this press release as part of the
       Company's undertakings towards the holders of its Series E Debentures.
       For a general discussion of the use of non-IFRS measures, such as EBITDA
       and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."
    8. The term "Adjusted EBITDA" is defined in the Series F Deed of Trust as
       earnings before financial expenses, net, taxes, depreciation and
       amortization, where the revenues from the Company's operations, such as
       the Talmei Yosef PV Plant, are calculated based on the fixed asset model
       and not based on the financial asset model (IFRIC 12), and before
       share-based payments, when the data of assets or projects whose
       Commercial Operation Date (as such term is defined in the Series F Deed
       of Trust) occurred in the four quarters that preceded the relevant date
       will be calculated based on Annual Gross Up (as such term is defined in
       the Series F Deed of Trust). The Series F Deed of Trust provides that for
       purposes of the financial covenant, the Adjusted EBITDA will be
       calculated based on the four preceding quarters, in the aggregate. The
       Adjusted EBITDA is presented in this press release as part of the
       Company's undertakings towards the holders of its Series F Debentures.
       For a general discussion of the use of non-IFRS measures, such as EBITDA
       and Adjusted EBITDA see above under "Use of Non-IFRS Financial Measures."

View original content:https://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-three-months-ended-march-31-2024-302186409.html

SOURCE Ellomay Capital Ltd.